Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

985 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.
Pönisch W, Bourgeois M, Moll B, Heyn S, Jäkel N, Wagner I, Rohrberg R, Hurtz HJ, Schmalfeld M, Aßmann M, Edelmann T, Mohren M, Hoffmann FA, Becker C, Schwarzer A, Schönfelder U, Zehrfeld T, Hensel G, Löschcke K, Krahl R, Ali HA, Niederwieser D. Pönisch W, et al. Among authors: bourgeois m. J Cancer Res Clin Oncol. 2013 Mar;139(3):499-508. doi: 10.1007/s00432-012-1339-3. Epub 2012 Nov 25. J Cancer Res Clin Oncol. 2013. PMID: 23184429
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.
Pönisch W, Moll B, Bourgeois M, Andrea M, Schliwa T, Heyn S, Schmalfeld M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Egert M, Stiegler R, Krahl R, Remane Y, Bachmann A, Lindner T, Weidhase L, Petros S, Fricke S, Vucinic V, Al Ali H, Niederwieser D. Pönisch W, et al. Among authors: bourgeois m. J Cancer Res Clin Oncol. 2013 Nov;139(11):1937-46. doi: 10.1007/s00432-013-1513-2. Epub 2013 Sep 18. J Cancer Res Clin Oncol. 2013. PMID: 24046251
Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma.
Pönisch W, Holzvogt B, Plötze M, Andrea M, Bourgeois M, Heyn S, Zehrfeld T, Hammerschmidt D, Schwarz M, Edelmann T, Becker C, Hoffmann FA, Schwarzer A, Kreibich U, Gutsche K, Reifenrath K, Winkelmann C, Krahl R, Remane Y, Hennig E, Schliwa T, Lindner T, Kaiser T, Vucinic V, Behre G, Niederwieser D. Pönisch W, et al. Among authors: bourgeois m. J Cancer Res Clin Oncol. 2014 Nov;140(11):1947-56. doi: 10.1007/s00432-014-1737-9. Epub 2014 Jun 19. J Cancer Res Clin Oncol. 2014. PMID: 24942335
ZIP10 as a potential therapeutic target in acute myeloid leukaemia.
Rolles B, Chatain N, Görg R, Vieri M, Tillmann-Tröster N, Bourgeois MG, Christen D, Walter J, Hillerbrand AC, Romine KA, Taylor KM, Bertram J, Jost E, Koschmieder S, Beier F, Stahl M, Brümmendorf TH, Rink L, Wessels I. Rolles B, et al. Among authors: bourgeois mg. Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20229. Online ahead of print. Br J Haematol. 2025. PMID: 40583520
Dynamic behavior of the nucleus pulposus within the intervertebral disc loading: a systematic review and meta-analysis exploring the concept of dynamic disc model.
Deneuville JP, Billot M, Cervantes A, Peterlongo S, Meyer M, Kolder M, Escande M, Bourgeois M, Pallot A, David R, Roulaud M, Ounajim A, Laslett M, Sarracanie M, Salameh N, Germaneau A, Rigoard P. Deneuville JP, et al. Among authors: bourgeois m. Front Bioeng Biotechnol. 2025 Jun 6;13:1582438. doi: 10.3389/fbioe.2025.1582438. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40547295 Free PMC article.
Brain Injury and Ketamine study (BIKe): a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on therapy intensity level and intracranial pressure in severe traumatic brain injury patients.
De Sloovere V, Mebis L, Wouters P, Guïza F, Boonen E, Bourgeois M, Dubois J, Ledoux D, Lormans P, Maréchal H, Van der Hauwaert E, Depreitere B, Meyfroidt G. De Sloovere V, et al. Among authors: bourgeois m. Trials. 2025 May 28;26(1):177. doi: 10.1186/s13063-025-08835-5. Trials. 2025. PMID: 40437634 Free PMC article.
New Animated Training and Certification Application for NIHSS.
Anderson A, White B, Bourgeois M, Champagne C, Rothermel E, Klein J, Aucoin J, Lyden P. Anderson A, et al. Among authors: bourgeois m. Stroke. 2025 Jun;56(6):1422-1427. doi: 10.1161/STROKEAHA.124.048924. Epub 2025 Apr 8. Stroke. 2025. PMID: 40197114
Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database.
Gajdos L, Buetti N, Tabah A, Ruckly S, Akova M, Sjöval F, Arvanti K, de Waele J, Bracht H, Barbier F, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network. Gajdos L, et al. Intensive Care Med. 2025 Mar;51(3):518-528. doi: 10.1007/s00134-025-07857-6. Epub 2025 Apr 7. Intensive Care Med. 2025. PMID: 40192823
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC; VEBIS SARI VE network team. Antunes L, et al. Influenza Other Respir Viruses. 2025 Mar;19(3):e70081. doi: 10.1111/irv.70081. Influenza Other Respir Viruses. 2025. PMID: 40059069 Free PMC article.
985 results